Tài liệu PARKINSON’S DISEASE pptx

... relatively certain that the prostate size, not the Parkinson’s disease, is the main culprit. If Parkinson’s is the major source of ADVANCED PARKINSON’S DISEASE /95 the symptoms, prostate surgery may ... effectively used for treatment of Parkinson’s, they are also responsible ADVANCED PARKINSON’S DISEASE /99 for many of the side effects experienced by people with Parkinson’s...

Ngày tải lên: 19/02/2014, 04:20

... (2001) The cellular pathology of Parkinson’s disease. Neuropathology 21: 315 –322 Takahashi H, Wakabayashi K (2005) Controversy: is Parkinson’s disease a single disease entity? Yes. Parkinsonism ... of this brain region to early and massive degen- eration in Parkinson’s disease. Parkinson’s disease (PD) is a progressive neu- rodegenerative disease which afflicts approx- imate...

Ngày tải lên: 14/02/2014, 17:20

... http://adsc.ohioalzcenter.org/. 90 Alzheimer’s Disease and Other Dementias Most research into the treatment of dementias is focused on trying to understand the disease process. As more is known about the disease process, ... Alzheimer’s disease, and is thus considered to be a risk factor for Alzheimer’s disease. However, there is not yet enough evidence to support the use of statins t...

Ngày tải lên: 14/02/2014, 18:20

Ngày tải lên: 19/02/2014, 11:20

... PD Stage 0 No signs of disease Stage 1 Unilateral disease Stage 1.5 Unilateral disease plus axial involvement Stage 2 Bilateral disease, without impaired balance Stage 2.5 Bilateral disease, with recovery ... Starkstein Marcelo Merello x Preface 1 1 Introduction Parkinson’s disease (PD) is a frequent neurologic disorder among elderly individuals. Whereas the hallmark of the disea...

Ngày tải lên: 28/03/2014, 22:21

... synaptic vesicle dynamics Parkinson’s disease Unknown ceramide; usually Lewy body inclusions LRRK2 12q12 Protein kinase Parkinson’s disease Ceramide metabolism and Lewy body disease J. Bras et al. 5768 ... ceramide metabolism Gene Chromosome Function Disease Ceramide metabolism and Lewy body inclusions GBA 1q21 Lysosomal hydrolase Gaucher’s disease ⁄ Parkinson’s disease in h...

Ngày tải lên: 18/02/2014, 14:20

... with early, mild Parkinson’s disease Parkinson’s Dis- ease Research Group of the United Kingdom. BMJ, 311, 1602 1607. 875: TREATMENT OF MOTOR COMPLICATIONS IN ADVANCED PARKINSON’S DISEASE Lees, ... et al. (2007) Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. The New England Journal of Medicine, 356 (1), 39 46. 90 PARKINSON’S DISEASE AND PAR...

Ngày tải lên: 14/02/2014, 17:20

... Modifi- cations of the iron-neuromelanin system in Parkinson’s disease. J Neurochem 96, 909–916. 4 Fasano M & Lopiano L (2008) Alpha-synuclein and Parkinson’s disease: a proteomic view. Expert Rev Proteomics ... The proteomic approach in Parkinson’s disease. Proteomics Clin Appl 1, 1428–1435. 12 Fasano M, Alberio T & Lopiano L (2008) Peripheral biomarkers of Parkinson’s dis...

Ngày tải lên: 15/02/2014, 01:20

... MINIREVIEW Emerging pathways in genetic Parkinson’s disease: Autosomal-recessive genes in Parkinson’s disease – a common pathway? Julia C. Fitzgerald and Helene Plun-Favreau Department ... pathway. Abbreviations AR-JP, autosomal-recessive juvenile-onset Parkinson’s disease; HtrA2, HtrA serine peptidase 2; LRRK2, leucine-rich repeat kinase 2; PD, Parkinson’s disease; PINK1, PTEN-...

Ngày tải lên: 18/02/2014, 14:20

Ngày tải lên: 10/12/2013, 17:15